Dysregulation of NOD2 was reported to be involved in the pathogenesis of Crohn’s disease (CD) and colitis related colon cancer7; and NOD2 gene polymorphisms have been associated with increased risk of lymphoma, colorectal, gastric, breast, ovarian, lung, and laryngeal cancers11. The gene discussed is NOD2; the disease is lymphoma.